Table IV.
Immunophenotype profile: relative values of T, B, NK cells in SLE patients with active vs. non-active disease.
| SLE | P | ||
|---|---|---|---|
| Active (n=14) | Non-active (n=41) | ||
| CD3 (%) | 76.42±9.04 | 76.88±9.50 | 0.526 |
| CD4 (%) | 43.52±14.00 | 45.63±11.00 | 0.217 |
| CD8 (%) | 29.61±13.42 | 28.23±10.81 | 0.700 |
| CD19 (%) | 11.09±6.12 | 10.20±6.32 | 0.280 |
| NK (%) | 11.61±8.06 | 11.74±7.25 | 0.977 |
| Ratio | 1.85±1.03 | 2.0±1.21 | 0.672 |
| Treg (%) | 4.78±1.08 | 11.50±4.71 | <0.001 |
| Breg (%) | 7.22±6.38 | 10.88±7.25 | 0.123 |
| Memory B (%) | 24.86±23.95 | 25.20±17.85 | 0.215 |
| Mature B (%) | 59.72±25.04 | 53.93±16.81 | 0.701 |
| IFN-α (pg/mL) | 0.49±1.81 | 0.40±0.91 | 0.870 |
| IL-17 (pg/mL) | 53.84±48.20 | 31.27±32.79 | 0.106 |